|
|
Title | Creator | Date |
1 |
|
Normative Data and Conversion Equation for Spectral-Domain Optical Coherence Tomography in an International Healthy Control Cohort | Rachel Kenney; Mengling Liu; Lisena Hasanaj; Binu Joseph; Abdullah A. Al-Hassan; Lisanne Balk; Raed Behbehani; Alexander U. Brandt; Peter A. Calabresi; Elliot M. Frohman; Teresa Frohman; Joachim Havla; Bernhard Hemmer; Hong Jiang; Benjamin Knier; Thomas Korn; Letizia Leocani; Elena H. Martínez-Lapi... | 2022-12 |
2 |
|
Internuclear Ophthalmoplegia Characterizes Multiple Sclerosis Rather Than Neuromyelitis Optica Spectrum Disease | Mahmoud M. Hamza; Basheer F. Alas; Connie Huang; Justin C. Quon; Lilyana Amezcua; Michael V. Robers; Kimberly K. Gokoffski | 2022-06 |
3 |
|
Optical Coherence Tomography Is Associated With Cognitive Impairment in Multiple Sclerosis | S. Dreyer-Alster; A. Gal; A. Achiron | 2022-03 |
4 |
|
Bruch Membrane Opening Minimum Rim Width in Neuromyelitis Optica | Lorane Bechet, MD; Philippe Cabre, MD, PhD; Harold Merle, MD, PhD | 2022-03 |
5 |
|
Is Neuroretinitis Associated With Multiple Sclerosis? | N. R. Miller; L. N. Johnson; T. Bakaeva; G. P. Van Stavern; A. G. Lee | 2022-03 |
6 |
|
Papilledema in a Patient Being Treated for Multiple Sclerosis | Larry Frohman, MD; Roger E. Turbin, MD; Peter J. Wawrzusin, MD; Gaurav Srivastava, MD; Nicole M. Sakla, DO | 2021-12 |
7 |
|
Interocular Difference in Retinal Nerve Fiber Layer Thickness Predicts Optic Neuritis in Pediatric-Onset Multiple Sclerosis | Amy T. Waldman, MD, MSCE; Leslie Benson, MD; John R. Sollee, BS; Amy M. Lavery, PhD; Geraldine W. Liu, ALM; Ari J. Green, MD, MCR; Emmanuelle Waubant, MD; Gena Heidary, MD, PhD; Darrel Conger, CRA; Jennifer Graves, MD, PhD; Benjamin Greenberg, MD, MHS | 2021-12 |
8 |
|
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis | Maria Cellerino; Luca Priano; Nicolò Bruschi; Giacomo Boffa; Maria Petracca; Giovanni Novi; Caterina Lapucci; Elvira Sbragia; Antonio Uccelli; Matilde Inglese | 2021-09 |
9 |
|
Shortened Pattern Electroretinogram Latency and Impaired Autoregulatory Dynamics to Steady-State Stimuli in Patients With Multiple Sclerosis | Hong Jiang; Giovana R. Gameiro; Huiling Hu; Pedro F. Monsalve; Chuanchui Dong; Jeffrey Hernandez; Silvia R. Delgado; Vittorio D. Porciatti; Jianhua Wang | 2021-03 |
10 |
|
Glial Fibrillary Acidic Protein Antibody - Another Antibody in the Multiple Sclerosis Diagnostic Mix | Meagan Seay, DO; Steven Galetta, MD | 2018-09 |
11 |
|
Multiple Sclerosis: B Cells Take Center Stage | Anne-Katrin Pröbstel, MD; Stephen L. Hauser, MD | 2018-06 |
12 |
|
Multiple Sclerosis Therapy: Are We Ready for a One-Size-Fits-All Approach? | Bruce A. C. Cree, MD, PhD, MAS | 2018-06 |
13 |
|
Evolution of Visual Outcomes in Clinical Trials for Multiple Sclerosis Disease-Modifying Therapies | Rachel C. Nolan, BA; Omar Akhand, BS; John-Ross Rizzo, MD, MSCI; Steven L. Galetta, MD; Laura J. Balcer, MD, MSCE | 2018-06 |
14 |
|
New Ways of 'Seeing' the Mechanistic Heterogeneity of Multiple Sclerosis Plaque Pathogenesis | Ethan I. Meltzer; Fiona E. Costello; Elliot M. Frohman; Teresa C. Frohman | 2018-03 |
15 |
|
Multiple Sclerosis: Eyes on the Future | Fiona E. Costello, MD, FRCPC; Jodie M. Burton, MD, MSc, FRCPC | 2018-03 |
16 |
|
Keep Your Eyes Wide Open: On Visual- and Vision-Related Measurements to Better Understand Multiple Sclerosis Pathophysiology | Yael Backner, Msc; Netta Levin, MD, PhD | 2018-03 |
17 |
|
Ocular Motor Manifestations of Multiple Sclerosis | Elodie Nerrant, MD; Caroline Tilikete, MD, PhD | 2017-09 |
18 |
|
Is Multiple Sclerosis Associated With a Lower Intraocular Pressure? | Norah S. Lincoff, MD; Andrea Buccilli, MD; Bianca Weinstock-Guttman, MD; Sandra Sieminski, MD; Sirin Gandhi, MD | 2017-09 |
19 |
|
Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?: Comment | Prem S. Subramanian; Jiawei Zhao; Sarita B. Davé; Jiangxia Wang' | 2017-03 |
20 |
|
Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?: Response. | Helena Felgueiras; Joana Parra; Simão Cruz; Pedro Pereira; Ana F. Santos; Adriana Rua; Dália Meira; Pedro Fonseca; Catarina Pedrosa; João N. Cardosa; Cristina Almeida; Maria Araújo; Ernestina Santos | 2017-03 |
21 |
|
Strabismus Surgery in Patients With Ocular Neuromyotonia: Potential Unmasking of the Condition and Effective Management Tool | J. Anna Kim, MD; Federico G. Velez, MD; Stacy L. Pineles, MD | 2016-09 |
22 |
|
Neuro-Ophthalmic Syndromes and Processing Speed in Multiple Sclerosis | Silvana L. Costa, PhD; Óscar F. Gonçalves, PhD; Nancy D. Chiaravalloti, PhD; John DeLuca, PhD; Jorge Almeida, PhD | 2016-03 |